Bassam Ghanem points to a large propensity-weighted target trial emulation suggesting no key outcome differences with empiric atypical coverage in non-severe community acquired pneumonia, challenging routine prescribing.
Time to revisit empiric atypical coverage in non-severe CAP?
Target trial emulation using a propensity-weighted cohort from 68 hospitals in Michigan >66,000 patients:
• No difference in time to clinical stability
Target trial emulation
from 68 hospitals in Michigan >66,000 patients:
No difference in time to clinical stability
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new expert voices, debates, and emerging ideas.
← Back to Healthcare